Acute lung injury timely associated with the administration of tocilizumab

Alojzija Hočevar; Anja Menard Srpčič; Katja Lakota; Miša Fister

doi:10.4081/reumatismo.2026.1947

January 29, 2026ReumatismoOpen Access

Acute lung injury timely associated with the administration of tocilizumab

View Full Paper

Ask AI

Bookmark

Share

Key Points

To explore the potential association between tocilizumab administration and acute lung injury.
Analysis of clinical cases documenting lung injury instances following tocilizumab administration.
Review of safety profiles associated with tocilizumab in autoimmune treatments.
Tocilizumab-induced acute lung injury was identified in several documented cases.
Reported lung injuries were rare but occurred shortly after treatment initiation.

Implication

Reveals acute lung injury after tocilizumab treatment, suggesting careful monitoring is necessary.

Abstract

Dear editor,The interleukin-6 receptor inhibitor tocilizumab has been successfully used to treat various autoimmune diseases and has an acceptable, well-established safety profile. Tocilizumab-induced lung injury has been rarely reported in the literature...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hočevar et al. (2026) studied this question.

synapsesocial.com/papers/6980fdc7c1c9540dea80f6ad https://doi.org/10.4081/reumatismo.2026.1947

View Full Paper

Ask AI

Bookmark

Share

Acute lung injury timely associated with the administration of tocilizumab

Key Points

Implication

Abstract

Discussion

Cite This Study

Acute lung injury timely associated with the administration of tocilizumab

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from Reumatismo

Keep reading

More related papers

More from Reumatismo